System Design for a Pharmaceutical Company

Jian Li () and Alan Paisey
Additional contact information
Jian Li: Kunda Tax Consulting (Shanghai) Limited

Chapter Chapter 15 in Transfer Pricing in China, 2019, pp 107-112 from Springer

Abstract: Abstract Some features of the pharmaceutical industry are unique. Internationally, it is subject to high regulation in terms of permission to proceed, and the pricing they can command. Pharmaceutical products are high-value added, research and development being the main factor involved, the introduction of a new drug being a very expensive, lengthy, and risky undertaking (Fig. 15.1).

Date: 2019
References: Add references at CitEc
Citations: View citations in EconPapers (1)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-981-13-7689-4_15

Ordering information: This item can be ordered from
http://www.springer.com/9789811376894

DOI: 10.1007/978-981-13-7689-4_15

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().